Recurrent deep vein thrombosis, ovarian carcinoma and antibodies to mitochondria M5 in a patient with asymptomatic primary "plus" antiphospholipid syndrome: An unusual combination

Clinical and Experimental Rheumatology

Volumn 25, Issue 6, 2007, Pages 890-895

  Asherson, Ronald A ^a   Schamroth Rapaport, Naomi ^b   Skudowitz, Ben ^c   Singh, Sham ^c   Marx, David ^d,e   Miesbach, Wolfgang ^d,e  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Millpark Hospital   (South Africa)

^c LANCET LABORATORIES   (South Africa)

^d Rosebank Clinic   (South Africa)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

Antibodies to mitochondria M5; Ovarian carcinoma; Primary "plus" antiphospholipid syndrome; Recurrent deep vein thromboses

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; ANTITHROMBIN III; C REACTIVE PROTEIN; CELECOXIB; D DIMER; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIPHENHYDRAMINE; ENOXAPARIN; ESOMEPRAZOLE; IMMUNOGLOBULIN G; LOW MOLECULAR WEIGHT HEPARIN; MITOCHONDRION ANTIBODY; MITOCHONDRION M5 ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTON PUMP INHIBITOR; SERTRALINE; THYROID ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VALPROIC ACID; WARFARIN;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD ANALYSIS; BRAIN EMBOLISM; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DRUG REEXPOSURE; ECHOGRAPHY; ENDOCARDITIS; FEMALE; HEART ATRIUM SEPTUM DEFECT; HOT FLUSH; HUMAN; HYPERIMMUNOGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LEG PAIN; LUNG EMBOLISM; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OVARY CARCINOMA; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; RECURRENT DISEASE; SURGICAL TECHNIQUE; SYSTEMIC LUPUS ERYTHEMATOSUS; THIRD TRIMESTER PREGNANCY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; MITOCHONDRIA; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE; VENOUS THROMBOSIS;

EID: 38649098517     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ASHERSON RA: A"primary"antiphospholipid syndrome? J Rheumatol 1998; 15: 1742-6.
2. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J et al.: The "primary" antiphospholipid syndrome: Major clinical and serological features Medicine (Baltimore) 1989: 68: 366-74.
3. MCCARTY GA, BADDOUR VT, GIESLER L. WAGENKNECHT DR, MCINTYRE JA: Antiphospholipid antibody syndrome (APS) in 227 patients: Comparison of IgG/IgM/LA + vs. IgA only vs. seronegative APS (SNAPS). Pitts M Autoimmun 2000: 15:A78 (Abstract p. 188, Special Issue. IXth International Symposium on aPL)
4. VÁZQUEZ-DEL MERCADO M, MARTÍN-MÁRQUEZ BT, PETRI MH, MARTÍNEZ-GARCÍA EA, MUNOZ-VALLE JF: Molecular mechanisms in normal pregnancy and rheumatic diseases. Clin Exp Rheumatol 2006: 24: 707-12.
5. TINCANI A, MERONI PL, BRUCATO A et al.: Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1985; 3: 321-6.
6. MEYER O, ABUAF N, CYNA L et al.: Antimitochondrial Type M5 antibodies and anticardiolipin antibodies in systemic lupus erythematosus and autoimmune diseases. Clin Exp Immunol 1997; 69: 495-42.
7. LAPERCHE S, ABUAF N, DESCHAMPS A, HOMBERG JC: Anti-mitochondrial antibodies are markers of antiphospholipid syndrome. Ann Biol Clin (Paris) 1994; 52: 375-9.
8. LAPERCHE S, ABUAF N, MEYER et al.: Association of antimitochondrial antibodies Type M5 and anti -beta 2 glycoprotein 1 antibodies in the antiphospholipid syndrome. J Rheumatol 1994; 21: 1678-3.
9. LA ROSA L, COVINI G, GALPERIN C et al.: Anti-mitochondrial M5 type antibody represents one of the serological markers for anti - phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein 1 antibodies. Clin Exp Immunol 1998; 112: 144-51.
10. SEINTURIER C, IMBERT B, PONARD D, DROUET C, DEBRU JL: Sneddon syndrome with antimitochondrial type M5 antibodies. Presse Med 2005; 34: 1011-2.
11. TROUSSEAU A: Phlegmasia alba dolens. In Clinique Medical de L'Hotel Dieu de Paris, Vol 3, London, The New Sydenham Society; 1865: 94.
12. BICK RL: Cancer-associated thrombosis (2003) N Engl J Med 349: 109-11.
13. GOMEZ-PUERTA JA, CERVERA R, ESPINOSA G et al.: Antiphospholipid antibodies associated with malignancies: Clinical and Pathological Characteristics of 120 Patients, Semin Arthritis Rheum 2006; 35: 322-32.
14. SCHVED JF, DUPUY-FONS C, BIRON C et al.: A prospective epdimiological study of the occurrence of antiphospholipid antibody; the Montpelier Antiphospholipid (MAP) Study. Haemostasis 1994; 24: 175-82.
15. RUFFATTI A, AVERSA S, DEL ROSS T, TONETTO S, FIORENTINO M: Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 1994; 21: 2162-3.
16. ASHERSON RA, CERVERA R: Antiphospholipid antibodies and malignancies (2000) In SHOENFELD Y (Ed.) Cancer and Autoimmunity. Elsevier, Amsterdam 93-102.
17. ASHERSON RA: Antiphospholipid antibodies, malignancies and paraproteinaemias. J Autoimmun 2000; 15: 117-22.
18. ASHERSON RA, GARCIA-CARRASCO M, ZERON MPL, RAMOS-CASALS M: Antiphospholipid antibodies and malignancies. In RA ASHERSON, CERVERA, J-C PIETTE, Y SHOENFELD (Eds.) The Antiphospholipid Syndrome 11. Elsevier Science B.V. 2002; 317-29.
19. PIETTE JC, CERVERA R, LEVY RA, NASONOV EL, TRIPLETT DA, SHOENFELD Y: The catastrophic antiphospholipid syndrome - Asherson's syndrome. Ann Med Interne 2003; 154: 195-6.
20. ASHERSON RA, CERVERA R, PIETTE JC et al.: Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 1-23.
21. ZUCKERMAN E, TOUBI E, GOLAN T et al.: Increased thromboembolic incidence in anticardiolipin-positive patients with malignancy. Br J Cancer 1995; 72: 447-51.
22. YOON KH, WONG A. SHAKESPEARE T, SIVALINGHAM P: High prevalence of the antiphospholipid antibodies In Asian cancer patients with thrombosis. Lupus 2003; 12:112-6.
23. JUDE B, GOUDERMAND J, DOLLE I et al.: Lupus anticoagulant: a clinical study of 100 cases. Clin Lab Haematol 1999; 10: 41-51.
24. MIESBACH W, SCHARRER I, ASHERSON R: Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 2006; 25: 840-4.
25. LECHNER K, PABINGER-FASCHING I: Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985; 15: 254-62.